SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $64,000 | -41.8% | 245,892 | -46.1% | 0.00% | – |
| Q1 2016 | $110,000 | -61.1% | 456,570 | -43.2% | 0.00% | – |
| Q4 2015 | $283,000 | -42.8% | 804,262 | +182.8% | 0.00% | -100.0% |
| Q3 2015 | $495,000 | -47.4% | 284,393 | -32.6% | 0.00% | 0.0% |
| Q2 2015 | $941,000 | +155.0% | 421,992 | +121.9% | 0.00% | 0.0% |
| Q1 2015 | $369,000 | -61.0% | 190,186 | -46.8% | 0.00% | 0.0% |
| Q4 2014 | $947,000 | -54.3% | 357,491 | -48.0% | 0.00% | -66.7% |
| Q3 2014 | $2,070,000 | -47.6% | 687,566 | -28.8% | 0.00% | -40.0% |
| Q2 2014 | $3,951,000 | +213.3% | 966,000 | +301.3% | 0.01% | +150.0% |
| Q4 2013 | $1,261,000 | -29.9% | 240,721 | -15.6% | 0.00% | -33.3% |
| Q3 2013 | $1,799,000 | +509.8% | 285,124 | +381.8% | 0.00% | +200.0% |
| Q2 2013 | $295,000 | – | 59,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |